Perbedaan Ciputra Development Tbk dan Champion Pacific Indonesia Tbk.: Ciputra Development Tbk diperdagangkan di Rp560 (kapitalisasi pasar 10,29 T, volume 24 jam 11,27 jt), sedangkan Champion Pacific Indonesia Tbk. diperdagangkan di Rp414 (kapitalisasi pasar 384,1 M, volume 24 jam 16,2 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 26,8× kapitalisasi pasar Champion Pacific Indonesia Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (11,27 jt vs 16,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | IGAR | |
|---|---|---|
Kapitalisasi Pasar | 10,29 T | 384,1 M |
Volume | 11,27 jt | 16,2 rb |
Lot | 112,75 rb | 162 |
Perputaran | 6,32 M | 6,65 jt |
Harga Rata-rata | 560,45 | 410,64 |
Nilai Transaksi | 6,32 M | 6,65 jt |
Harga Ekuilibrium Indikatif | 560 | 414 |
Volume Ekuilibrium Indikatif | 3,05 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Selengkapnya di halaman IGAR →